[Long-term Effects of Intensive Intervention on Changes in Lifestyle in Patients with Hyperfibrinogenaemia and Moderate-high Cardiovascular Risk]

Overview

Journal Aten Primaria

Specialty Public Health

Date 2017 Jul 22

PMID 28729040

Authors

Laura Illamola Martin

Juan Jose Rodriguez Cristobal

Carlos Alonso-Villaverde

Betlem Salvador-Gonzalez

Irene Moral Pelaez

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine whether the benefit on cardiovascular risk factors (CVRF) persists 5 years after an intensive intervention in lifestyle (LS) that lasted 2 years, in patients with hyperfibrinogenaemia and moderate or high cardiovascular risk.

Design: multicentre prospective observational study.

Location: 13 Primary Care Centres in Barcelona and Baix Llobregat.

Participants: A total of 300 patients who completed the EFAP study (146 intervention group, 154 control group).

Interventions: The EFAP study, conducted on patients with normal cholesterol and elevated fibrinogen showed that lifestyle interventions are effective in reducing CVRF. After the EFAP study, the 2 groups followed the usual controls, and re-assessed after 5 years.

Main Measurements: Age, gender, cardiovascular diseases (CVD) (diabetes, dyslipidaemia, hypertension, obesity), laboratory parameters (fibrinogen, glucose, full blood count, cholesterol, triglycerides), blood pressure, weight, height, body mass index (BMI), tobacco and alcohol use, REGICOR.

Results: At 5 years, the intervention group had a lower abdominal circumference (98 and 101cm, respectively, P=.043), a lower weight (76.30 and 75.04kg, respectively, P<.001), and BMI (29.5 and 30.97kg/m, P=.018). Fibrinogen level was lower in the intervention group (330.33 and 320.27 mg/dl respectively, P < .001), and REGICOR risk was also lower in the intervention group (5.65 and 5.59 respectively, P < .06).

Conclusion: The benefit of an intensive intervention in LS for 2 years to reduce CVRF persists at 5 years, but decreases its intensity over time. It is recommended to repeat the interventions periodically to maintain the beneficial effect on LS.

References

Rodriguez Cristobal J, Alonso-Villaverde Grote C, Trave Mercade P, Perez Santos J, Pena Sendra E, Munoz Lloret A . Randomised clinical trial of an intensive intervention in the primary care setting of patients with high plasma fibrinogen in the primary prevention of cardiovascular disease. BMC Res Notes. 2012; 5:126. PMC: 3317867. DOI: 10.1186/1756-0500-5-126. View

Marrugat J, Vila J, Baena-Diez J, Grau M, Sala J, Ramos R . [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]. Rev Esp Cardiol. 2011; 64(5):385-94. DOI: 10.1016/j.recesp.2010.12.011. View

Paramo J, Rodriguez J, Orbe J . [Fibrinogen. An old hemostatic protein with a new function: non-invasive marker of subclinical atherosclerosis]. Med Clin (Barc). 2005; 124(20):790-4. DOI: 10.1157/13075852. View

Yano K, Grove J, Chen R, Rodriguez B, Curb J, Tracy R . Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men. Arterioscler Thromb Vasc Biol. 2001; 21(6):1065-70. DOI: 10.1161/01.atv.21.6.1065. View

Hooper L, Summerbell C, Higgins J, Thompson R, Capps N, Smith G . Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ. 2001; 322(7289):757-63. PMC: 30550. DOI: 10.1136/bmj.322.7289.757. View

Steptoe A, Kerry S, Rink E, Hilton S . The impact of behavioral counseling on stage of change in fat intake, physical activity, and cigarette smoking in adults at increased risk of coronary heart disease. Am J Public Health. 2001; 91(2):265-9. PMC: 1446539. DOI: 10.2105/ajph.91.2.265. View

Moerloose P, Boehlen F, Neerman-Arbez M . Fibrinogen and the risk of thrombosis. Semin Thromb Hemost. 2010; 36(1):7-17. DOI: 10.1055/s-0030-1248720. View

Kunutsor S, Kurl S, Zaccardi F, Laukkanen J . Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysis. Atherosclerosis. 2016; 245:171-80. DOI: 10.1016/j.atherosclerosis.2015.12.020. View

Wing R . Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010; 170(17):1566-75. PMC: 3084497. DOI: 10.1001/archinternmed.2010.334. View

10.

Danesh J, Lewington S, Thompson S, Lowe G, Collins R, Kostis J . Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005; 294(14):1799-809. DOI: 10.1001/jama.294.14.1799. View

11.

Rodriguez Cristobal J, Villaverde Grote C, Tibau Llarden N, Juan Babot O, Andrades Corrales A, Pena Sendra E . [Relationship between cholesterol and fibrinogen in two populations of different geographical location of Catalonia]. Rev Clin Esp. 2004; 204(8):405-9. DOI: 10.1157/13064313. View

12.

Rodriguez-Rodriguez E, Lopez-Plaza B, Lopez-Sobaler A, Ortega R . [Overweight and obesity among Spanish adults]. Nutr Hosp. 2011; 26(2):355-63. DOI: 10.1590/S0212-16112011000200017. View

13.

Reiner Z, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O . ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32(14):1769-818. DOI: 10.1093/eurheartj/ehr158. View

14.

Rodriguez Cristobal J, Benavides Marquez F, Villaverde Grote C, Pena Sendra E, Flor Serra F, Trave Mercade P . [Randomised clinical trial of an intensive intervention into life-styles of patients with hyperfibrinogenaemia in primary prevention of cardiovascular pathology in primary health care]. Aten Primaria. 2005; 35(5):260-4. PMC: 7684374. DOI: 10.1157/13072792. View

15.

Sheikholeslami Vatani D, Ahmadi S, Ahmadi Dehrashid K, Gharibi F . Changes in cardiovascular risk factors and inflammatory markers of young, healthy, men after six weeks of moderate or high intensity resistance training. J Sports Med Phys Fitness. 2012; 51(4):695-700. View

16.

Li X, Luo Y, Xu Y, Li J, Hu D . Relationship of ankle-brachial index with all-cause mortality and cardiovascular mortality after a 3-year follow-up: the China ankle-brachial index cohort study. J Hum Hypertens. 2009; 24(2):111-6. DOI: 10.1038/jhh.2009.49. View

17.

Brown A, Gouldstone A, Fox E, Field A, Todd W, Shakher J . Description and preliminary results from a structured specialist behavioural weight management group intervention: Specialist Lifestyle Management (SLiM) programme. BMJ Open. 2015; 5(4):e007217. PMC: 4390730. DOI: 10.1136/bmjopen-2014-007217. View